[HTML][HTML] Glucocorticoids are double-edged sword in the treatment of COVID-19 and cancers
R Yang, Y Yu - International journal of biological sciences, 2021 - ncbi.nlm.nih.gov
Glucocorticoids are important steroid hormones. As an outstanding scientific discovery, the
scientist who discovered glucocorticoids was awarded the Nobel Prize in Physiology and …
scientist who discovered glucocorticoids was awarded the Nobel Prize in Physiology and …
Corticosteroids for treatment of COVID-19: effect, evidence, expectation and extent
VK Patel, E Shirbhate, P Patel, R Veerasamy… - Beni-Suef University …, 2021 - Springer
Abstract Background The World Health Organization (WHO) announced the COVID-19
occurrence as a global pandemic in March 2020. The treatment of SARS-CoV-2 patients is …
occurrence as a global pandemic in March 2020. The treatment of SARS-CoV-2 patients is …
Corticosteroids: A boon or bane for COVID-19 patients?
Several drugs and antibodies have been repurposed to treat COVID-19. Since the outcome
of the drugs and antibodies clinical studies have been mostly inconclusive or with lesser …
of the drugs and antibodies clinical studies have been mostly inconclusive or with lesser …
[HTML][HTML] Effectiveness and safety of glucocorticoids to treat COVID-19: a rapid review and meta-analysis
S Lu, Q Zhou, L Huang, Q Shi, S Zhao… - Annals of …, 2020 - ncbi.nlm.nih.gov
Background Glucocorticoids are widely used in the treatment of various pulmonary
inflammatory diseases, but they are also often accompanied by significant adverse …
inflammatory diseases, but they are also often accompanied by significant adverse …
Corticosteroids for COVID-19: worth it or not?
Pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induced
COVID-19 implied the presence of excessive proinflammatory cytokines and chemokines in …
COVID-19 implied the presence of excessive proinflammatory cytokines and chemokines in …
Glucocorticoids and COVID-19
S Bruscoli, PG Puzzovio, M Zaimi, K Tiligada… - Pharmacological …, 2022 - Elsevier
Abstract Coronavirus Disease 19 (COVID-19) is associated with high morbidity and mortality
rates globally, representing the greatest health and economic challenge today. Several …
rates globally, representing the greatest health and economic challenge today. Several …
[HTML][HTML] The Role of Glucocorticoids in the Management of COVID-19
VI Alexaki, H Henneicke - Hormone and Metabolic Research, 2021 - thieme-connect.com
Coronavirus disease 2019 (COVID-19), caused by an infection with the novel coronavirus
SARS-CoV-2, has resulted in a global pandemic and poses an emergency to public health …
SARS-CoV-2, has resulted in a global pandemic and poses an emergency to public health …
Dexamethasone for severe COVID-19: how does it work at cellular and molecular levels?
The coronavirus disease 2019 (COVID-19) caused by infection of the severe respiratory
syndrome coronavirus-2 (SARS-CoV-2) significantly impacted human society. Recently, the …
syndrome coronavirus-2 (SARS-CoV-2) significantly impacted human society. Recently, the …
[HTML][HTML] Clinical efficacy of glucocorticoid on the treatment of patients with COVID-19 pneumonia: A single-center experience
Y Hu, T Wang, Z Hu, X Wang, Z Zhang, L Li… - Biomedicine & …, 2020 - Elsevier
The aim of the present study was to identify the clinical efficacy of glucocorticoid therapy on
the treatment of patients with Coronavirus Disease 2019 (COVID-19) pneumonia. Clinical …
the treatment of patients with Coronavirus Disease 2019 (COVID-19) pneumonia. Clinical …
[PDF][PDF] Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus pneumonia: protocol of a randomized controlled trial
YH Zhou, YY Qin, YQ Lu, F Sun, S Yang, V Harypursat… - Chin Med J, 2020 - med.uminho.pt
Background: At the end of 2019, a novel coronavirus outbreak emerged in Wuhan, China,
and its causative organism has been subsequently designated the 2019 novel coronavirus …
and its causative organism has been subsequently designated the 2019 novel coronavirus …